{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:47:54Z","timestamp":1790117274283,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3876,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/labinvest.2012.53","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T08:45:12Z","timestamp":1332751512000},"page":"827-841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitro"],"prefix":"10.1016","volume":"92","author":[{"given":"Jianguo","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohua","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2012.53_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2036.2007.03538.x","article-title":"Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis","volume":"27","author":"Tsochatzis","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1038\/labinvest.2012.53_bib2","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1038\/labinvest.2012.53_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med"},{"key":"10.1038\/labinvest.2012.53_bib4","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.2012.53_bib5","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/01.CIR.0000037282.92395.AE","article-title":"Diabetic macrovascular disease: the glucose paradox?","volume":"106","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/labinvest.2012.53_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-4889(00)00087-2","article-title":"The biology of the receptor for advanced glycation end products and its ligands","volume":"1498","author":"Schmidt","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/labinvest.2012.53_bib7","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1073\/pnas.0401588101","article-title":"Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2012.53_bib8","first-page":"1699","article-title":"Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues","volume":"143","author":"Brett","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2012.53_bib9","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1073\/pnas.93.20.11047","article-title":"Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins","volume":"93","author":"Li","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2012.53_bib10","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2012.53_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hep.1840150211","article-title":"Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture","volume":"15","author":"Friedman","year":"1992","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"10.1038\/labinvest.2012.53_bib12","first-page":"S84","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"Kisseleva","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1038\/labinvest.2012.53_bib13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1517\/14728222.11.9.1231","article-title":"Present and future therapeutic strategies in non-alcoholic fatty liver disease","volume":"11","author":"Calamita","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"10.1038\/labinvest.2012.53_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjp.0707580","article-title":"Curcumin: potential for hepatic fibrosis therapy?","volume":"153","author":"O'Connell","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1038\/labinvest.2012.53_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/mol.107.039818","article-title":"Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation","volume":"73","author":"Fu","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1038\/labinvest.2012.53_bib16","doi-asserted-by":"crossref","first-page":"G20","DOI":"10.1152\/ajpgi.00474.2002","article-title":"Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth","volume":"285","author":"Xu","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Part 1","key":"10.1038\/labinvest.2012.53_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/BJ20040928","article-title":"Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro","volume":"384","author":"Zheng","year":"2004","journal-title":"Biochem J"},{"key":"10.1038\/labinvest.2012.53_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.freeradbiomed.2007.04.016","article-title":"De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation","volume":"43","author":"Zheng","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1038\/labinvest.2012.53_bib19","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1440-1746.2007.04943.x","article-title":"Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis","volume":"22","author":"Hyogo","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1038\/labinvest.2012.53_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00535-007-2152-7","article-title":"Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells","volume":"43","author":"Iwamoto","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1038\/labinvest.2012.53_bib21","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1016\/S0021-9258(18)42741-X","article-title":"Immunochemical detection of advanced glycosylation end products in vivo","volume":"267","author":"Makita","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2012.53_bib22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1073\/pnas.81.2.583","article-title":"Accelerated age-related browning of human collagen in diabetes mellitus","volume":"81","author":"Monnier","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2012.53_bib23","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/clinchem\/43.9.1563","article-title":"Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system","volume":"43","author":"Wrobel","year":"1997","journal-title":"Clin Chem"},{"key":"10.1038\/labinvest.2012.53_bib24","doi-asserted-by":"crossref","first-page":"47376","DOI":"10.1074\/jbc.M301088200","article-title":"Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism","volume":"278","author":"Miele","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2012.53_bib25","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1210\/endo.142.7.8254","article-title":"A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes","volume":"142","author":"Camp","year":"2001","journal-title":"Endocrinology"},{"key":"10.1038\/labinvest.2012.53_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/labinvest.2009.115","article-title":"Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress","volume":"89","author":"Lin","year":"2009","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2012.53_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/abio.2000.4753","article-title":"Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods","volume":"285","author":"Schmittgen","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1038\/labinvest.2012.53_bib28","doi-asserted-by":"crossref","first-page":"25994","DOI":"10.1074\/jbc.271.42.25994","article-title":"Suppression of stellate cell type I collagen gene expression involves AP-2 transmodulation of nuclear factor-1-dependent gene transcription","volume":"271","author":"Chen","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2012.53_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.bjp.0707542","article-title":"Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling","volume":"153","author":"Chen","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1038\/labinvest.2012.53_bib30","doi-asserted-by":"crossref","first-page":"G883","DOI":"10.1152\/ajpgi.00450.2005","article-title":"Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor","volume":"290","author":"Zheng","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.2012.53_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/labinvest.3700532","article-title":"The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro","volume":"87","author":"Zhou","year":"2007","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2012.53_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/labinvest.2008.20","article-title":"Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells","volume":"88","author":"Lin","year":"2008","journal-title":"Lab Invest"},{"issue":"Suppl 3","key":"10.1038\/labinvest.2012.53_bib33","first-page":"S102","article-title":"Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation","volume":"21","author":"Tsukamoto","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1038\/labinvest.2012.53_bib34","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1210\/en.2008-1601","article-title":"Curcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signaling","volume":"150","author":"Tang","year":"2009","journal-title":"Endocrinology"},{"key":"10.1038\/labinvest.2012.53_bib35","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1476-5381.2009.00261.x","article-title":"Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells","volume":"157","author":"Kang","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1038\/labinvest.2012.53_bib36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/labinvest.2009.93","article-title":"Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1","volume":"89","author":"Kang","year":"2009","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2012.53_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.mce.2010.12.028","article-title":"Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2","volume":"333","author":"Lin","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1038\/labinvest.2012.53_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/138945009787122905","article-title":"Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets","volume":"10","author":"Sourris","year":"2009","journal-title":"Curr Drug Targets"},{"key":"10.1038\/labinvest.2012.53_bib39","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1681\/ASN.V1191656","article-title":"Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease","volume":"11","author":"Tanji","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/labinvest.2012.53_bib40","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2353\/ajpath.2009.090138","article-title":"Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia","volume":"175","author":"Torreggiani","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2012.53_bib41","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1517\/13543784.17.7.983","article-title":"Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications","volume":"17","author":"Yamagishi","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1038\/labinvest.2012.53_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1196\/annals.1433.055","article-title":"Advanced glycation end product homeostasis: exogenous oxidants and innate defenses","volume":"1126","author":"Vlassara","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/labinvest.2012.53_bib43","doi-asserted-by":"crossref","first-page":"C145","DOI":"10.1152\/ajpcell.00350.2007","article-title":"AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation","volume":"294","author":"Cai","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/labinvest.2012.53_bib44","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.2042-7158.1994.tb03258.x","article-title":"Curcuminoids as potent inhibitors of lipid peroxidation","volume":"46","author":"Sreejayan","year":"1994","journal-title":"J Pharm Pharmacol"},{"key":"10.1038\/labinvest.2012.53_bib45","doi-asserted-by":"crossref","first-page":"10811","DOI":"10.1074\/jbc.272.16.10811","article-title":"Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase","volume":"272","author":"Camp","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2012.53_bib46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/endo.140.1.6457","article-title":"c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity","volume":"140","author":"Camp","year":"1999","journal-title":"Endocrinology"},{"key":"10.1038\/labinvest.2012.53_bib47","first-page":"1894","article-title":"Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer","volume":"7","author":"Sharma","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.2012.53_bib48","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.bjc.6601623","article-title":"Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration","volume":"90","author":"Garcea","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1038\/labinvest.2012.53_bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00210-007-0171-9","article-title":"Unchanged serum levels of advanced glycation endproducts in patients with liver disease","volume":"375","author":"Butscheid","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1038\/labinvest.2012.53_bib50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-2007-973830","article-title":"The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes","volume":"115","author":"Scharnagl","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1038\/labinvest.2012.53_bib51","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1210\/jc.2005-2559","article-title":"Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein","volume":"91","author":"Basta","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.2012.53_bib52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1056-8727(02)00203-9","article-title":"Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN)","volume":"17","author":"Schiel","year":"2003","journal-title":"J Diabetes Complications"},{"key":"10.1038\/labinvest.2012.53_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5301\/EJO.2010.4447","article-title":"Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy","volume":"21","author":"Ghanem","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1038\/labinvest.2012.53_bib54","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1096\/fj.02-0030fje","article-title":"Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin","volume":"16","author":"Okamoto","year":"2002","journal-title":"FASEB J"},{"key":"10.1038\/labinvest.2012.53_bib55","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0006-2952(98)00237-8","article-title":"Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats","volume":"56","author":"Sajithlal","year":"1998","journal-title":"Biochem Pharmacol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201253","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722026836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722026836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:50:42Z","timestamp":1758397842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722026836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0023683722026836"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2012.53","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitro","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2012.53","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}